世界银行集团（WBG）：2022年持续应对抗微生物药物耐药性行动报告-国家经验案例系列（英文版）（40页）.pdf

1、Sustaining Action Against Antimicrobial Resistance i Sustaining Action Against Antimicrobial Resistance A CASE SERIES OF COUNTRY EXPERIENCESPublic Disclosure AuthorizedPublic Disclosure AuthorizedPublic Disclosure AuthorizedPublic Disclosure AuthorizedSustaining Action Against Antimicrobial Resistan

2、ce A CASE SERIES OF COUNTRY EXPERIENCESCopyright 2022 by International Bank for Reconstruction and Development/The World Bank and World Health Organization1818 H Street NW,Washington,DC 20433 Telephone:202-473-1000;Internet:www.worldbank.org Some rights reserved.This work is available under the Crea

3、tive Commons Attribution-3.0 IGO license(CC BY 3.0 IGO)https:/creativecommons.org/licenses/by/3.0/igo/.Suggested citation.Sustaining Action Against Antimicrobial Resistance:A Case Series of Country Experiences.Washington,DC:World Bank and the World Health Organization;2022.License:CC BY 3.0 IGO.The

4、findings,interpretations,and conclusions expressed in this work do not necessarily reflect the views of The World Bank,its Board of Executive Directors,or the governments they represent,or those of WHO.The World Bank and WHO do not guarantee the accuracy,completeness,or currency of the data included

5、 in this work and does not assume responsibility for any errors,omissions,or discrepancies in the information,or liability with respect to the use of or failure to use the information,methods,processes,or conclusions set forth.The boundaries,colors,denominations,and other information shown on any ma

6、p in this work do not imply any judgment on the part of The World Bank and/or WHO concerning the legal status of any territory or the endorsement or acceptance of such boundaries.Terminology used to refer to countries,territories and areas as well as representation of countries,territories and areas